Never-Event Payment Policies - How Health Plans Are Getting Tough on Preventable Hospital Errors; Implementing 'Medical Homes' to Improve Patient Care and the Bottom Line


AISHealth.com - Specialized Business Information for Health Care Managers Health Reform Pharmacy Benefit Consumer-Directed Care Compliance Market Data Health Plans
 HOME
 New on the Site
Customer Service
Sample Newsletters MarketPlace
AIS Products & Services

E-Savings Club weekly specials

Free E-Mail Newsletters
Health Business Daily
Government News
Sign Up for Free E-Mail Newsletters

Health Business Job Openings

Health Business Meetings

People on the Move
 
Health Plans
General Business Issues
Product News
Company Intelligence
Disease Management
Blue Cross and Blue Shield
Medicare Advantage
Managed Medicaid
Health Plan Products
Compliance
Compliance Strategies
HIPAA Resource Center
Government Resources
Compliance Products
Pharmacy Benefit
Pharmacy Benefit Mgmt.
Specialty Pharmacy
Drug Mgmt. Products
Consumer-Directed Care
Articles on CDH
CDH Data
CDH Products
Market Data
Managed Care Enrollment
Pharmacy Benefit Mgmt.
Data Products
 
Health Reform
Presidential Candidates' Proposals
Federal Legislation
State Legislation
 
MarketPlace
Newsletters
Looseleaf Guides
Books, Directories & Reports
Live Seminars & Audioconferences
Alphabetical Listing

Health Care Links
 
Search AISHealth.com
 
Visit AISEducation.com for more news and strategic information for today's business leaders
 
Audio CD and written materials of
AIS's audioconference on
February 9, 2005
Implications of Recent Final Regulations for Medicare Advantage and Part D

On January 21, CMS released comprehensive final regulations for Medicare Advantage (MA) and the new Part D drug benefit that contain significant changes from rules proposed in August, particularly for MA. These regulations will have a huge impact on the feasibility of participation in MA and Part D, and organizations have very limited time to analyze them before key deadlines for applications begin to kick in (e.g., Feb. 15 for some MA applications). Understanding the nuances of these lengthy, complex new rules is urgent if your organization is exploring becoming a regional PPO, prescription drug plan, or MA prescription drug plan, or is planning to expand or start a local MA PPO.

Sponsored by Atlantic Information Services, Inc., publisher of Managed Care Week, Medicare Advantage News and Drug Benefit News, and A Guide to the Medicare Drug Benefit

Speakers
Designed For

Shipping Information

Written Materials

Print an order form:
If you do not wish to place your order online, click here to download a printable order form (PDF file), then submit your order via fax or mail, as directed on the form.

 

 
Order Now (Secure Site)
Order Now Audio CD and Printed Materials ($267)
Pub code: CMADT
View Cart View Cart

Many organizations have been waiting for these final regulations to decide whether and how to participate in the $400-billion-plus Medicare drug benefit that begins Jan. 1, 2006. The final regs are out, the deadlines are set, and the time is NOW for health plans, PBMs, employer groups and labor unions, and pharmaceutical companies to understand these new rules and position their companies accordingly.

“I was very impressed with your conference. It was the best audioconference I have attended in a long time.”

— Edward J. McAdam Sr., Director Contract Administration, Sankyo Pharma Inc., who listened to a recent AIS audioconference on Part D by John Gorman.

Among the numerous changes on the MA side: CMS made it easier for regional PPOs to provide coverage in rural and other areas with limited hospital availability; revised its interpretation of the moratorium on local PPOs in a way that may cause an immediate rethinking of intentions not just for 2006 but also for 2007; and gave MA plans the authority to make mid-year benefit enhancements — but only during specific parts of the year.

On the drug-benefit side, CMS modified the processes by which beneficiaries will be able to get non-formulary drugs in a timely manner; changed the way pharmacy access standards are applied; accelerated the implementation of e-prescribing standards; provided more flexibility in applying the "actuarial equivalence" standard for employers that keep offering a drug benefit to retirees; and provided new specifics on the transition of dual eligibles from Medicaid to Medicare for purposes of drug coverage.

You need experts to help you determine what these and other significant changes in the final regulations mean and, given the tight deadlines, you need those experts RIGHT AWAY.

Listen to John Gorman and Maureen Miller — two of the foremost experts in Medicare managed care and Part D — interpret the final regulations and provide your organization with sound business strategies for the future. You'll get all of the details on:

  • Major changes between the draft and final regulations on both the MA and Part D sides.
  • The implications of the changes on MA product opportunities, including regional and local PPOs, and on prescription drug plans (PDPs).
  • How the final regulations impact employer-sponsored retiree drug benefits.
  • The migration of dual eligibles from Medicaid to the Part D drug benefit.
  • Specific strategies you can use to take advantage of the new opportunities created by these final regulations — and avoid the new pitfalls.

 

Speakers

JOHN GORMAN is president and CEO of Gorman Health Group, the leading consulting firm specializing in Medicare managed care and the new Part D regulations. Before starting his company in 1996, Mr. Gorman served as assistant to the director of CMS-predecessor HCFA's Office of Managed Care. Prior to that, he was staff director for U.S. Rep. John Conyers, Jr., then chairman of the House Government Operations Committee. Mr. Gorman specializes in strategic planning and business development for the health care industry, with particular emphasis on federal programs and regulation.

MAUREEN MILLER, senior consultant at Gorman Health Group, was in key positions at HCFA for 20 years before joining John Gorman's company. Most recently, she was senior policy analyst for HCFA's Medicare managed care program and had an integral role in the agency's development of Medicare Advantage and provider-sponsored organization regulations. A registered nurse with a master's degree in public health, Ms. Miller's roles at HCFA included product development, legislative reform and regulatory affairs specifically pertaining to Medicare managed care.

Moderator: Jim Gutman, vice president and executive editor of Atlantic Information Services, Inc.

 

Designed Especially For

  • Health plan CEOs, strategic planners, product development and marketing executives, financial managers, and pharmacy directors
  • Executives of pharmacy benefit management companies
  • Pharmaceutical company executives and marketers
  • Directors of managed care contracting for providers and pharmacy chains
  • Top benefits executives at employers
  • Executives of health care information technology firms
  • Attorneys and consultants

 

Shipping Information

Audio CDs and written materials are shipped via UPS. Please give us your street address when you order (UPS does not deliver to PO boxes). You should receive your order within 5-7 business days.* Shipping cost is $5.

Rush Orders: Please call us at 800-521-4323 to place a rush order.* We will overnight your order for an additional charge of $30, or you can give us your FedEx or UPS account number and we will charge the shipping to your account. Rush orders placed after 3:00pm EST will not be shipped out until the next business day.

*Please note that shipping of CDs and materials will begin within three weeks of the conference.

 

Written Materials

Practical information on developing effective strategies for MA and Part D in light of key changes in the final rules is also included.

 

For further information call 800-521-4323 or e-mail customerserv@aispub.com


Advertise With AIS

Privacy

Site Map



Copyright © 2008 by Atlantic Information Services, Inc. All rights reserved.
1100 17th Street, NW, Suite 300, Washington, DC 20036
Phone 202-775-9008 or 800-521-4323; E-mail
customerserv@aispub.com